This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a ... Empagliflozin (Jardiance) to treat type 2
The FDA continues to investigate and has not determined whether the diabetes drug increases the risk of leg and foot amputations.
The partner of a different patient, who had diabetes, would regularly “punish” her by taking her insulin away, and thus the diabetes was poorly controlled, Dr. ... help you, for example, manage their diabetes.
This patient most likely has new-onset type 2 diabetes mellitus (recent-onset polyuria and nocturia, high random glucose levels) and classic features of excess mineralocorticoid activity, including hypertension, metabolic alkalosis, ... Adrenal adenomas
Little treatments, lots of time best for back pain | Internal Medicine Meeting 2019 News | ACP Internist
catastrophizing, avoiding activities out of fear (of further injury, for example), and having depression, anxiety, obesity, comorbidities such as diabetes, headaches, or asthma, or a physically demanding job, Dr.
For diabetes mellitus, the following information will be needed: type of diabetes (i.e., due to underlying condition, chemical- or drug-induced, type 1, type 2); body system affected; complication or ... manifestation; and, for type 2 diabetes, whether
Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) to improve glucose control in adults with diabetes. ... The former agent, a long-acting insulin analog for both type 1 and 2 diabetes, is subcutaneously
of the time in patients with diseases that internists commonly see and treat—heart disease, diabetes and inflammatory disorders. ... Our scores were abysmal, and we started with diabetes because we knew that 30% of those patients have depression,” Dr.
O’Connell. At the same time, the homeless population experiences the full spectrum of bread-and-butter internal medicine problems, such as diabetes, hypertension, cardiovascular disease, and chronic obstructive pulmonary disease,
Insulin glargine injection (Basaglar), a long-acting human insulin analog, for improving glycemic control in adults with type 1 or type 2 diabetes.